Skip to main content
    D

    DaVita HealthCare Partners Inc (DVA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $189.16
    +8.46 (+4.68%)

    Market Cap: $11.60B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(27/39)
    Avg Surprise
    +6.42%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$3.55
    Range$3.39 - $4.02
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    6
    30d
    EPS Estimate DriftChange to current
    90d ago$3.93-9.7%
    60d ago$3.92-9.5%
    30d ago$3.58-0.7%
    7d ago$3.58-0.7%
    Current$3.55
    Revenue Consensus
    $3.5B
    Range$3.5B - $3.6B
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$5.01
    Range$4.58 - $5.76
    7 analysts
    Revenue Consensus
    $3.8B
    Range$3.6B - $4.1B
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$5.01---
    Sep 26EST
    		-$3.55---
    Jun 26
    Reported Aug 4
    		$4.02$4.01+0.25%Beat+36.3%
    Mar 26
    Reported May 5
    		$2.87$2.33+23.18%Beat+43.5%
    Dec 25
    Reported Feb 2
    		$3.40$3.19+6.58%Beat+51.8%
    Sep 25
    Reported Oct 29
    		$2.51$3.17-20.82%Miss-3.1%
    Jun 25
    Reported Aug 5
    		$2.95$2.75+7.27%Beat+13.9%
    Mar 25
    Reported May 12
    		$2.00$2.02-0.99%Miss-16.0%
    Dec 24
    Reported Feb 13
    		$2.24$2.13+5.16%Beat+19.8%
    Sep 24
    Reported Oct 29
    		$2.59$2.72-4.78%Miss-9.1%
    Jun 24
    Reported Aug 6
    		$2.59$2.63-1.52%Miss+24.5%
    Mar 24
    Reported May 2
    		$2.38$1.92+23.96%Beat+50.6%
    Dec 23
    Reported Feb 13
    		$1.87$1.66+12.65%Beat+216.9%
    Sep 23
    Reported Nov 7
    		$2.85$2.04+39.71%Beat+96.6%
    Jun 23
    Reported Aug 3
    		$2.08$1.74+19.54%Beat-9.6%
    Mar 23
    Reported May 8
    		$1.58$1.22+29.51%Beat-1.9%
    Dec 22
    Reported Feb 22
    		$0.59$0.91-35.16%Miss-70.8%
    Sep 22
    Reported Oct 28
    		$1.45$1.76-17.61%Miss-38.6%
    Jun 22
    Reported Aug 1
    		$2.30$2.08+10.58%Beat-12.9%
    Mar 22
    Reported May 5
    		$1.61$1.87-13.90%Miss-23.0%
    Dec 21
    Reported Feb 10
    		$2.02$1.80+12.22%Beat+21.0%
    Sep 21
    Reported Oct 28
    		$2.36$2.26+4.42%Beat+31.1%
    Jun 21
    Reported Aug 3
    		$2.64$2.17+21.66%Beat+35.4%
    Mar 21
    Reported Apr 29
    		$2.09$1.79+16.76%Beat+14.2%
    Dec 20
    Reported Feb 11
    		$1.67$1.87-10.70%Miss-10.2%
    Sep 20
    Reported Oct 29
    		$1.80$1.44+25.00%Beat+17.6%
    Jun 20
    Reported Jul 30
    		$1.95$1.30+50.00%Beat+59.8%
    Mar 20
    Reported May 5
    		$1.83$1.47+24.49%Beat+101.1%
    Dec 19
    Reported Feb 10
    		$1.86$1.66+12.05%Beat+106.7%
    Sep 19
    Reported Nov 5
    		$1.53$1.24+23.39%Beat+173.2%
    Jun 19
    Reported Aug 1
    		$1.22$1.11+9.91%Beat+16.2%
    Mar 19
    Reported May 7
    		$0.91$0.93-2.15%Miss-13.3%
    Dec 18
    Reported Feb 13
    		$0.90$0.90+0.00%Beat-2.2%
    Sep 18
    Reported Nov 7
    		$0.56$0.88-36.36%Miss-30.9%
    Jun 18
    Reported Aug 1
    		$1.05$0.97+8.25%Beat+14.1%
    Mar 18
    Reported May 3
    		$1.05$0.92+14.13%Beat+32.9%
    Dec 17
    Reported Feb 13
    		$0.92$0.92+0.00%Beat-6.1%
    Sep 17
    Reported Nov 7
    		$0.81$0.94-13.83%Miss-
    Jun 17
    Reported Aug 1
    		$0.92$0.90+2.22%Beat-
    Mar 17
    Reported May 2
    		$0.79$0.81-2.47%Miss-
    Dec 16
    Reported Feb 16
    		$0.98$0.91+7.69%Beat-

    Key Metrics

    Valuation
    P/E Ratio14.78EV/EBITDA8.02x
    Price/FCF7.61xFCF Yield13.14%
    Profitability
    Profit Margin6.05%Operating Margin16.10%
    ROE88.50%ROIC16.46%
    Financial Health
    Debt/Equity-14.09xInterest Coverage3.40x
    Current Ratio1.47xQuick Ratio1.41x
    Trading Statistics
    Beta0.80Avg Volume650.21K
    52-Week High$247.4952-Week Low$101.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$180.46
    SMA 20$179.77
    SMA 50$180.35
    SMA 200$173.00
    EMA 10$181.50
    EMA 20$181.06
    EMA 50$185.51
    EMA 200$177.02

    MACD

    Line: -0.44Signal: -1.77Hist: 1.33

    ADX

    ADX: 14.7+DI: 25.5-DI: 19.1

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down60.0
    PSAR$174.55

    Bollinger Bands

    Upper Band$187.09
    Lower Band$172.44
    %B Position815%(Upper)
    Band Width1.14

    RSI (14-Day)

    Neutral
    60.7

    Momentum Oscillators

    Stoch %K82.6
    Stoch %D72.2
    Williams %R-0.6
    ROC (10d)7.3%
    Momentum12.81
    CCI (20d)171.2
    MFI (14d)68.1

    Volatility Measures

    ATR (14d)$4.77(2.5%)
    StdDev (20d)3.66
    Hist Vol28.9%(Moderate)

    Volume Flow

    VWAP$186.99
    OBV8.2M
    AD Line-4.5M
    CMF (20d)-0.165

    Volume Metrics

    Avg Vol (20d)614.7K
    Vol Ratio1.0x
    VWMA (20d)$180.15

    Pivot Points

    R3$187.31
    R2$185.77
    R1$183.24
    Pivot Point$181.70
    S1$179.17
    S2$177.63
    S3$175.10

    Advanced Oscillators

    TSI-2.68
    Ultimate Osc49.7
    KST-7.18

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.55B$3.42B$3.62B$3.42B$3.38B$3.22B$3.29B$3.26B$3.19B$3.07B$3.15B$3.12B
    Cost of Revenue$2.39B$2.34B$2.41B$2.33B$2.26B$2.24B$2.23B$2.15B$2.14B$2.08B$2.14B$2.07B
    Gross Profit$1.16B$1.07B$1.21B$1.09B$1.12B$983.87M$1.07B$1.11B$1.04B$991.58M$1.01B$1.05B
    Operating Expenses$583.08M$591.40M$649.20M$581.70M$580.14M$544.93M$503.95M$576.84M$538.02M$507.73M$617.47M$558.08M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$423.46M$421.91M$472.36M$414.37M$412.81M$374.09M$414.48M$393.53M$367.85M$362.48M$401.47M$376.88M
    Operating Income$579.00M$481.89M$561.07M$505.77M$537.84M$438.94M$565.36M$534.88M$506.40M$483.85M$389.91M$495.94M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$152.29M$145.13M$157.28M$155.71M$146.06M$135.06M$138.72M$144.66M$107.48M$99.42M$96.19M$98.08M
    Income Before Tax$435.01M$341.23M$382.76M$308.80M$368.93M$286.33M$413.73M$373.43M$371.44M$371.79M$289.07M$378.21M
    Income Tax Expense$91.79M$66.20M$76.73M$68.55M$93.71M$54.12M$64.49M$77.67M$71.69M$65.81M$58.49M$68.85M
    Net Income$343.22M$275.04M$331.03M$240.25M$275.22M$232.22M$349.25M$295.76M$299.75M$305.98M$230.57M$309.36M
    EBITDA$755.11M$664.19M$726.74M$642.00M$689.69M$597.84M$726.56M$705.11M$654.58M$658.29M$580.53M$664.71M
    EBIT$587.30M$486.37M$540.04M$464.51M$514.99M$421.39M$552.45M$518.10M$478.92M$471.20M$385.26M$476.29M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DVA

    News

    DaVita Inc. (DVA) Stock Forecasts

    The article "DaVita Inc. (DVA) Stock Forecasts" on Yahoo Finance Canada appears to be a placeholder or an article that failed to load content. It displays navigation elements, market data summaries...

    Yahoo! Finance Canada•10/16/26•Neutral

    A Look at DaVita Inc (DVA) After 4.7% Gain -- GF Value $197.72 v

    DaVita Inc (DVA) shares recently gained 4.7%, bringing its price to $189.16. The stock is considered undervalued according to its GF Value™ of $197.72, and boasts a strong GF Score™ of 89/100...

    GuruFocus•10/15/26•Neutral

    DaVita Inc. stock outperforms competitors on strong trading day

    DaVita Inc. (DVA) saw its stock advance by 4.68% on Thursday, closing at $189.16. This strong performance occurred on a positive trading day for the broader market...

    MarketWatch•10/15/26•Bullish

    Seven analysts target USD 233.43 for DaVita stock

    Seven analysts have set an average 12-month target of USD 233.43 for DaVita Inc. stock, with four buy and three hold ratings. The company's second-quarter revenue reached USD 3.55 billion, a 5.2% increase year-over-year...

    ad-hoc-news.de•10/15/26•Bullish

    NeoGenomics, Inc. (NEO) Stock Forecasts

    This article provides a stock forecast for NeoGenomics, Inc. (NEO), a company specializing in oncology diagnostic testing and consultative services. An Argus report from October 14, 2026, is highlighted...

    Yahoo! Finance Canada•10/15/26•Neutral

    DVA Valuation and Fair Value

    P/E
    14.8x
    Forward P/E
    9.9x
    EV/EBITDA
    8.0x
    P/FCF
    7.6x
    PEG
    0.5x
    P/B
    -16.0x
    See GNG's fair value

    DVA Profitability: Margins, ROIC and FCF

    Gross margin
    32.4%
    Operating margin
    16.1%
    Net margin
    6.0%
    ROIC
    16.5%
    ROE
    88.5%
    FCF margin
    11.5%
    FCF yield
    13.1%

    DVA Competitors

    CompanyTicker
    Smith & Nephew SNATS IncSNN
    Bio-Techne CorpTECH
    Tempus AI, Inc. Class A Common StockTEM
    Repligen CorporationRGEN
    Encompass Health CorpEHC
    Elanco Animal HealthELAN
    BrightSpring Health Services, Inc. Common StockBTSG
    Fresenius Medical Care CorporationFMS

    Sector: Healthcare

    DVA Analyst Ratings

    Consensus
    Hold
    Analysts
    8
    Strong Buy
    0
    Buy
    3
    Hold
    4
    Sell
    0
    Strong Sell
    1

    DVA Bull Case vs Bear Case

    Bull case

    • DVA earns a 16.5% return on invested capital.

    DVA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    2.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $3.55
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 6 down

    Frequently Asked Questions About DVA

    Does DVA pay dividends?

    DaVita HealthCare Partners Inc (DVA) does not currently pay a regular dividend.

    What is DVA's P/E ratio?

    DaVita HealthCare Partners Inc has a price-to-earnings (P/E) ratio of 14.78.

    What is DVA's market cap?

    DaVita HealthCare Partners Inc (DVA) has a market capitalization of $11.60B with a current stock price of $189.16.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In